Abstract:Background: NS5A protein plays a key role in HCV replication. DAG181PA, an inhibitor of NS5A protein, preclinical data showed that it has favorable in vitro and in vivo properties. Our aim is to evaluate the tolerability, safety and pharmacokinetics of DAG181PA in healthy volunteers. Methods: A randomized, double-blind, placebo-controlled, single-ascending dose (30,100,200 and 400mg) and multiple-ascending dose (100mg and 200mg once daily for 7 days) study was performed in 32 and 24 healthy subjects respectively. An additional group of 15 subjects received an open-label dose of DAG181PA 100mg in the fasted condition and after a meal. Pharmacokinetic assessments included plasma, urine and faecal samples. Results: All doses of DAG181PA were well tolerated both as single oral doses or once oral doses for 7 days. All the AEs were mild except one subject with moderate urticaria in the placebo group, resolving with symptomatic treatment. After administration a single dose of DAG181PA 30 to 100 mg, DAG181PA values increased approximately dose proportionally in area under the concentration-time curve (AUC) and maximum plasma concentration (Cmax), while increased slowly from 100mg to 400mg. Approximately 64.8 to 76.1% of the doses were excreted in feces. Steady state was reached by day 7 of dosing with minimal accumulation of DAG181PA. Administration of DAG181PA with food delayed its absorption and reduced its exposure relative to the fasted state, with a median Tmax 4.0 to 10.0h, mean Cmax 519 to 189 ng/mL and mean AUC0-t 7800 to 3970h*ng/mL in fasting and fed conditions. Conclusion: DAG181PA was considered safe and well tolerated in healthy subjects. Less than dose-proportional increases in its exposure after single oral administration of DAG181PA 100 to 400 mg, which primarily excreted in feces. Minimal accumulation was predicted and observed for DAG181PA. The extent of absorption was significantly affected by food.

Toleration of penciclovir in healthy volunteers

Topical Treatment of All-Trans Retinoic Acid Cream Combined with Penciclovir Cream for Verruca Plana: A Multiple Centre,double-Blind and Control Study

Pharmacokinetics and Safety of Pitavastatin Calcium Tablets in Chinese Healthy Volunteers after a Single Oral Dose Administration

Toleration of vardenafil tablets in healthy volunteers after a single oral administration

Study on bioequivalence of cilostazol table in healthy volunteers

Study of Relative Bioavailability of Aciclovir Tablet in Healthy Volunteers

Tolerability Trial of Peramivir Trihydrate and Sodium Chloride Injection in Healthy Volunteers

Relative Bioavailability and Bioequivalence of Famciclovir Tablets in Healthy Volunteers

Distribution to the skin of penciclovir after oral famciclovir administration in healthy volunteers: comparison of the suction blister technique and cutaneous microdialysis

Bioequivalence of Valaciclovir Hydrochlordide Tablets in Healthy Volunteers

Pharmacokinetics and Relative Bioavailability Study of Valaciclovir Hydrochloride Tablets in Chinese Healthy Volunteers

Clinical research of short-term and low dose valaciclovir for cytomegalovirus pneumonia prophylaxis in renal transplant recipients

Determination of Penciclovir in Human Plasma Using LC with Fluorescence Detection: Application to a Bioequivalence Study

A Phase I Study for Evaluating the Safety and Tolerability of Zhishenjieyu Capsule

Tolerance of Octohydroaminoacridine Succinate Tablets after Single Dose Administration in Chinese Healthy Volunteers

Tolerance study of ulinastatin injection in Chinese healthy volunteers

Tolerance and Safety of Buagafuran in Chinese Healthy Volunteers

Safety, Tolerability and Pharmacokinetics of a Novel Oral Hepatitis C Virus NS5A Inhibitor DAG181PA Capsules in Chinese Healthy Volunteers

Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database

PhaseⅠSafety and Tolerability Study of Multiple Oral Dosing D-polymannuronicate Tablets in Healthy Volunteers

Safety and tolerance of (+)zopiclone after a single oral administration